Cargando…

Antiviral anticoagulation

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a novel envelope virus that causes coronavirus disease 2019 (COVID‐19). Hallmarks of COVID‐19 are a puzzling form of thrombophilia that has elevated D‐dimer but only modest effects on other parameters of coagulopathy. This is combined w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pryzdial, Edward L. G., Sutherland, Michael R., Lin, Bryan H., Horwitz, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354393/ https://www.ncbi.nlm.nih.gov/pubmed/32685886 http://dx.doi.org/10.1002/rth2.12406

Ejemplares similares

Virus–Platelet Associations
por: Pryzdial, Edward L. G., et al.
Publicado: (2017)

Thrombin A-Chain: Activation Remnant or Allosteric Effector?
por: Carter, Isis S. R., et al.
Publicado: (2010)

Coagulation and complement: Key innate defense participants in a seamless web
por: Pryzdial, Edward L. G., et al.
Publicado: (2022)

A biochemical network can control formation of a synthetic material by sensing numerous specific stimuli
por: Hun Yeon, Ju, et al.
Publicado: (2015)

The role of direct oral anticoagulants in the era of COVID-19: are antiviral therapy and pharmacogenetics limiting factors?
por: Roguljić, Hrvoje, et al.
Publicado: (2022)

Anticoagulation in the Elderly
por: Robert-Ebadi, Helia, et al.
Publicado: (2010)

Antiviral, immunomodulatory, and anticoagulant effects of quercetin and its derivatives: Potential role in prevention and management of COVID-19
por: Manjunath, Souparnika H., et al.
Publicado: (2022)

Correction of haemorrhagic shock-associated coagulopathy and impaired haemostasis by plasma, prothrombin complex concentrates or an activated protein C-targeted DNA aptamer in mice
por: Eltringham-Smith, Louise J., et al.
Publicado: (2023)

Antivirals/direct oral anticoagulants interaction: Anticoagulation drug level increased and off label use: 12 case reports
Publicado: (2020)

Anticoagulation in atrial fibrillation: the present and the future
por: Dweck, Marc R, et al.
Publicado: (2012)

Balancing Antiplatelet and Anticoagulant Therapies in Patients with Cardiovascular Disease
por: Carreras, Edward T., et al.
Publicado: (2013)

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants
por: Favaloro, Emmanuel J., et al.
Publicado: (2022)

Anticoagulation in Patients Aged ≥75 years with Atrial Fibrillation: Role of Novel Oral Anticoagulants
por: Ng, Kuan H., et al.
Publicado: (2013)

Latest advances in innate antiviral defence
por: Irving, Aaron, et al.
Publicado: (2009)

Hemorrhagic stroke and anticoagulation in COVID-19
por: Dogra, Siddhant, et al.
Publicado: (2020)

Interferon-inducible antiviral effectors
por: Sadler, Anthony J., et al.
Publicado: (2008)

Antiviral Compounds from Myxobacteria
por: Mulwa, Lucky S., et al.
Publicado: (2018)

Use of anticoagulants in elderly patients: practical recommendations
por: Robert-Ebadi, Helia, et al.
Publicado: (2009)

Pre‐dispensing of antivirals to high‐risk individuals in an influenza pandemic
por: Goldstein, Edward, et al.
Publicado: (2010)

Anticoagulants and Osteoporosis
por: Signorelli, Salvatore Santo, et al.
Publicado: (2019)

The Role of Anticoagulation Clinics in the Era of New Oral Anticoagulants
por: Testa, Sophie, et al.
Publicado: (2012)

Patients and Their Physician’s Perspectives About Oral Anticoagulation in Patients With Atrial Fibrillation Not Receiving an Anticoagulant
por: Cannon, Christopher P., et al.
Publicado: (2023)

Anticoagulant therapy in pediatrics
por: Dabbous, Mariam K., et al.
Publicado: (2014)

Coagulation and anticoagulation in idiopathic pulmonary fibrosis
por: Crooks, Michael G., et al.
Publicado: (2015)

Reversing anticoagulant effects of novel oral anticoagulants: role of ciraparantag, andexanet alfa, and idarucizumab
por: Hu, Tiffany Y, et al.
Publicado: (2016)

Pharmacogenetics of Anticoagulants
por: Rane, Anders, et al.
Publicado: (2010)

New horizons in anticoagulation: Direct oral anticoagulants and their implications in oral surgery
por: Serrano-Sánchez, Víctor, et al.
Publicado: (2017)

Updates in Anticoagulation Therapy Monitoring
por: McRae, Hannah L., et al.
Publicado: (2021)

Perioperative management of patients on direct oral anticoagulants
por: Dubois, Virginie, et al.
Publicado: (2017)

Anticoagulation in the cirrhotic patient
por: Turco, Laura, et al.
Publicado: (2019)

Anticoagulation in COVID – 19: An Update
por: Tiwari, Nishant R, et al.
Publicado: (2020)

Results expression for tests used to measure the anticoagulant effect of new oral anticoagulants
por: Tripodi, Armando
Publicado: (2013)

Thrombin Generation Biomarkers Decline With Parenteral Anticoagulation—An Overlooked Means of Anticoagulation Monitoring?
por: McFarland, Craig P., et al.
Publicado: (2018)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

Efficacy and safety of novel anticoagulants in the elderly
por: Karamichalakis, Nikolaos, et al.
Publicado: (2016)

Licensing Natural Killers for Antiviral Immunity
por: Cronk, John M., et al.
Publicado: (2021)

Alopecia in anticoagulated patients
por: Marques, Marcos Arêas, et al.
Publicado: (2020)

Direct-acting Oral Anticoagulants: An Overview
por: Salem, Hatem H.
Publicado: (2017)

Anticoagulation for Prosthetic Valves
por: Kaneko, Tsuyoshi, et al.
Publicado: (2013)

Advances in Antiviral Delivery Systems and Chitosan-Based Polymeric and Nanoparticulate Antivirals and Antiviral Carriers
por: Žigrayová, Dominika, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_amf38277b8m47c2gkmsa8g2lqm